期刊文献+

120例直肠癌病理特征及预后 被引量:1

Clinical pathological features and prognosis of 120 patients with rectal cancer
原文传递
导出
摘要 目的:探讨直肠癌的病理特征与预后的关系。方法:应用单因素和多因素分析方法,回顾性分析有完整临床病理资料和随访资料的120例直肠癌患者的临床特点、病理特征及其对预后的影响。结果:单因素分析显示,性别、年龄、肿瘤部位与预后无相关性,分化程度和TNM分期与预后均有相关性。应用Cox比例危险回归模型分析显示,肿瘤的分化程度和TNM分期是影响直肠癌患者术后生存的独立因素。结论:影响直肠癌患者预后独立因素是肿瘤的分化程度和TNM分期,新的观察指标需进一步研究。 Objective : To evaluate the relationship between clinical pathological features and prognosis of rectal cancer after operation. Methods: Clinical features, pathologic factors and survival rate of 120 patients with rectal cancer after operation were univariately and multivariately analyzed. Results: Univariate analysis showed that sex, age, and tumor location of rectal cancer patients were not related to their survival rate, while multivariate analysis showed that histological type and TNM stage were the independent prognostic factors for rectal cancer. Conclusion : The survival of patients with rectal cancer is related to the histological type and TNM stage of rectal cancer. Further study is needed to investigate the new factors.
出处 《军医进修学院学报》 CAS 2009年第3期293-294,共2页 Academic Journal of Pla Postgraduate Medical School
关键词 结直肠肿瘤 病理状态 体征和症状 预后 colorectal neoplasms pathological conditions, signs and symptoms prognosis
  • 相关文献

参考文献2

二级参考文献12

  • 1Shephers NA, Saraga EP, Love SB, et al. Prognostic factors in colonic cancer. Histopathology, 1989,14:613-620.
  • 2Ponz de Leon M, Sant M, Micheli A, et al. Clinical and pathologic prognostic indicators in colorectal cancer: a population-based study.Cancer, 1992,69:625-635.
  • 3Deans GT, Patterson CC, Parks TG, et al. Colorectal carcinoma:importance of clinic and pathological factors in survival. Ann R Coil Surg Engl, 1994,76:59-64.
  • 4Park YJ, Park K.l, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases.World J Surg, 1999,23:721-726.
  • 5Newland RC, Dent OF, Kyttle MN, et al. Pathological determinants of survival associated with colorectal cancer with lymph node metastasis: a multivariate analysis of 579 patients. Cancer, 1994,73:2076-2082.
  • 6Roncucci L, Fante R, Losi L, et al. Survival for colon and rectal cancer in a population based cancer. Br J Surg, 1995,32A:295.
  • 7Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alteration in colorectal cancer Gastroenterology, 1992,102:1136-1141.
  • 8Ratto C, Soft L, Ippoliti M, et al. Prognostic factors in colorectal cancer literature review for clinical application. Dis Colon Rectum, 1998,41:1033-1049.
  • 9Crucitti F, Sofo L, Doglietto GB, et al. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol Suppl, 1991,2:76-82.
  • 10黄忠荣.EVALUATION OF PHYSIOLOGIC FUNCTION OF COLONIC POUCHANASTOMOSES AFTER EXCISION FOR RECTAL CANCER[J].Chinese Journal of Cancer Research,1999,11(4):299-302. 被引量:1

共引文献126

同被引文献20

  • 1杨艳芳,胡晓琴,梁小波,李佩珍.p16基因在结直肠癌中的表达及与术后生存期的关系[J].现代预防医学,2012,39(22):5911-5912. 被引量:3
  • 2王晓娜,梁寒,王家仓,王宝贵.1829例结直肠癌患者的临床病理特征及预后分析[J].中华胃肠外科杂志,2004,7(6):439-442. 被引量:36
  • 3侯振江,张宗英.p27基因在肿瘤研究中的进展[J].国外医学(临床生物化学与检验学分册),2005,26(12):960-960. 被引量:6
  • 4张云斌,徐海涛,董新舒.直肠癌扩大根治术中几个原则问题的探讨[J].实用肿瘤学杂志,2006,20(1):46-48. 被引量:9
  • 5WICHMANN MW, MULER C, HORNUNG HM, et al. Gender differences in long-term survival of patients with colorectal can?cer[J]. BrJ Surg, 2001, 88: 1092-1098.
  • 6CHOU CL, CHANG SC, LIN TC, et al. Differences in clinico?pathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution[J]. AmJ Surg, 2011, 202: 574-582.
  • 7SUI X,JIN L, HUANG X, et al. P53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment[J]. Autophagy, 2011, 7(6): 565-571.
  • 8BIRCHARD KR, HOANGJK, HERNDONJEJR, et al. Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival[J]. Cancer, 2009, 115(3): 581-586.
  • 9LARA PN, REDMAN MW, KELLY K, et al. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small cell lung cancer: Results from Southwest Oncology Group ran?domized trials[J].J Clin Oncol, 2008, 26(3): 463-467.
  • 10CHOI H, CHARNSANGAVEJ C, DE CASTRO FS, et al, CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG-PET findings[J]. AmJ Roentgenal, 2004, 183: 1619- 1628.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部